[ccp4bb] Structural Biologist - permanent position in Central London

2009-12-04 Thread Andrew Turnbull
es employer Andrew Turnbull, PhD Structural Biologist Cancer Research Technology Ltd Birkbeck College University of London Malet Street London WC1E 7HX UK Tel: +44 (0)20 7631 6837 Fax: +44 (0)20 7631 6803 This communication is from Cancer Research Technology L

[ccp4bb] Structural Biologist - permanent position in Central London

2008-02-27 Thread Andrew Turnbull
uoting the relevant reference number, to the HR Manager, CRT, Sardinia House, Sardinia Street, London, WC2A 3NL or by email to [EMAIL PROTECTED] No Agencies Closing Date: Thursday 20th March 2008 We have a no smoking policy CRT is an equal opportunities employer -- Andrew Tur

[ccp4bb] Structural Biologist - permanent position in Central London

2008-07-07 Thread Andrew Turnbull
Structural Biologist - permanent position Central London (Reference XR0708) Cancer Research Technology (CRT) is a specialist technology transfer company which develops discoveries arising from Cancer Research UK and worldwide prestigious oncology organisations into potential therapies and d

[ccp4bb] Post-doctoral post at ICR with CR-UK Catalyst Grant

2023-03-27 Thread Andrew Turnbull
Posted on behalf of Prof. Terry Rabbitts: - Post-doctoral post at ICR to develop LMO2 Protac compounds for leukaemia treatment The Institute of Cancer Research (ICR), London, is one of the world's most influential cancer research institutes, with an

[ccp4bb] Post-doctoral post at ICR with CR-UK Catalyst Grant

2023-05-24 Thread Andrew Turnbull
Posted on behalf of Prof. Terry Rabbitts: - Post-doctoral post at ICR to develop LMO2 PROTAC compounds for leukaemia treatment Our Chromosomal Translocation and Intracellular Antibody Therapeutics Group is within the Division of Cancer Therapeutics an

[ccp4bb] Post-doctoral post at ICR with CR-UK Catalyst Grant

2023-07-10 Thread Andrew Turnbull
Posted on behalf of Prof. Terry Rabbitts: - Post-doctoral post at ICR to develop LMO2 PROTAC compounds for leukaemia treatment Our Chromosomal Translocation and Intracellular Antibody Therapeutics Group is within the Division of Cancer Therapeutics a

[ccp4bb] Higher Scientific Officer post at ICR to develop LMO2 PROTAC compounds for leukaemia treatment

2023-11-30 Thread Andrew Turnbull
Posted on behalf of Prof. Terry Rabbitts: - Higher Scientific Officer post at ICR to develop LMO2 PROTAC compounds for leukaemia treatment Our Chromosomal Translocation and Intracellular Antibody Therapeutics Group is within the Division of Cancer Th